Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Di | Pre-Q4 Earnings: Should Byrna Stock be in Your Portfolio? | ||
Di | UBS Group Q4 Earnings & Revenues Increase Y/Y, Credit Loss Expenses Up | ||
Di | Expedia Gears Up to Report Q4 Earnings: Buy, Sell or Hold the Stock? | ||
Di | KKR Q4 Earnings Beat on Higher Revenues & AUM, Expenses Rise Y/Y | ||
Di | Jacobs Q1 Earnings & Revenues Beat Estimates, Stock Rises | ||
Di | Amcor's Earnings Meet Estimates in Q2, Revenues Decrease 0.3% Y/Y | ||
Di | Will Healthy Revenue Growth Boost Pinterest's Q4 Earnings Results? | ||
Di | Apollo Global Q4 Earnings Beat as AUM Rises, Revenues Decline Y/Y | ||
Di | Incyte Gears Up to Report Q4 Earnings: Here's What You Should Know | ||
Di | Universal Technical to Report Q1 Earnings: Here's What to Expect | ||
Di | Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales | ||
Di | Merck Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '25 View | ||
Di | Molina Healthcare to Report Q4 Earnings: What Do the Estimates Say? | ||
Di | EL Stock Plummets Despite Q2 Earnings Beat Amid China Weakness | ||
Di | TransDigm Surpasses Q1 Earnings Estimates, Hikes '25 EPS View | ||
Di | CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's Imfinzi | ||
Di | Healthpeak's Q4 FFO Beats Estimates, Same-Store NOI Rises | ||
Di | Trump's Tariffs Hit TSLA Hard, Shares Fall 5%: What's Next? | ||
Di | Affirm Q2 Earnings Incoming: Time to Buy, Sell, or Hold the Stock? | ||
Di | Take-Two Gears Up to Report Q3 Earnings: What's in the Cards? | ||
Di | Schneider Earnings in Line, Revenues Miss Estimates in Q4 | ||
Di | ERIC to Upgrade Ooredoo's Network System: Will the Stock Benefit? | ||
Di | Xylem's Q4 Earnings & Revenues Beat Estimates, Orders Up Y/Y | ||
Di | RTX's Arm Secures a Contract to Aid Standard Missile-2 and 6 Programs | ||
Di | Equity Residential Q4 FFO Meets Estimates, Rental Income Rises Y/Y |